Synonyms: MPC-1304 | MPC1304 | Sapresta®
aranidipine is an approved drug (Japan (1996))
Compound class:
Synthetic organic
Comment: Aranidipine (MPC-1304) is a long-acting, dihydropyridine-type Ca2+ channel blocker [1] that produces an hypotensive effect in vivo [2]. Activation of K+ channels may also be involved in aranidipine-induced vasodilation, as identified in a rat model [3]. We show the compound with no specified stereochemistry to represent the racemic mixture of enantiomers. It has been reported that the (S) enantiomer of aranidipine is responsible for most of the pharmacological activity of the racemate [4].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (Japan (1996)) |
IUPAC Name |
3-O-methyl 5-O-(2-oxopropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
International Nonproprietary Names | |
INN number | INN |
7071 | aranidipine |
Synonyms |
MPC-1304 | MPC1304 | Sapresta® |
Database Links | |
CAS Registry No. | 86780-90-7 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2104030 |
DrugBank Ligand | DB09229 |
GtoPdb PubChem SID | 458923779 |
PubChem CID | 2225 |
Search Google for chemical match using the InChIKey | NCUCGYYHUFIYNU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | NCUCGYYHUFIYNU |
Search PubMed clinical trials | aranidipine |
Search PubMed titles | aranidipine |
Search PubMed titles/abstracts | aranidipine |
UniChem Compound Search for chemical match using the InChIKey | NCUCGYYHUFIYNU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NCUCGYYHUFIYNU-UHFFFAOYSA-N |